Frankfurt - Delayed Quote EUR
Madrigal Pharmaceuticals, Inc. (YDO1.F)
260.10
+1.90
+(0.74%)
At close: May 16 at 9:55:02 PM GMT+2
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BATE KENNETH M Director | Conversion of Exercise of derivative security | Feb 27, 2025 | 1,912 |
| CRAVES FREDERICK B Director | Conversion of Exercise of derivative security | Mar 13, 2025 | 383,547 |
| DALY JAMES M. Director | Conversion of Exercise of derivative security | Feb 27, 2025 | 1,912 |
| DIER MARDI C Chief Financial Officer | Sale | Mar 10, 2025 | 10,440 |
| FOUSE JACQUALYN A. Director | Stock Award(Grant) | Mar 10, 2025 | 894 |
| HUNTSMAN CAROLE Officer | Stock Award(Grant) | Mar 5, 2025 | 11,990 |
| KELLEY SHANNON T General Counsel | Stock Award(Grant) | Mar 5, 2025 | 10,477 |
| SIBOLD WILLIAM JOHN Chief Executive Officer | Stock Award(Grant) | Mar 5, 2025 | 117,369 |
| TAUB REBECCA A Officer and Director | Stock Award(Grant) | Mar 5, 2025 | 1,116,580 |
| WALTERMIRE ROBERT E. Officer | Conversion of Exercise of derivative security | Mar 5, 2025 | 5,789 |